All of the following agents are useful in acromegaly EXCEPT:
**Core Concept**
Acromegaly is a disorder caused by excess growth hormone (GH) secretion, leading to various systemic effects, including insulin resistance, joint pain, and facial changes. Effective management of acromegaly involves medications that reduce GH levels or inhibit its effects.
**Why the Correct Answer is Right**
Somatostatin analogs, such as octreotide and lanreotide, are commonly used to treat acromegaly by inhibiting the release of GH from the anterior pituitary gland. Dopamine agonists like cabergoline can also decrease GH levels by stimulating dopamine receptors in the pituitary gland. Pegvisomant is a GH receptor antagonist that blocks the effects of GH on peripheral tissues. These agents are useful in managing acromegaly.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it is not a standard treatment for acromegaly. However, I do not have the option A to provide an explanation for. It must be provided for a complete response.
**Clinical Pearl / High-Yield Fact**
The primary goal of acromegaly treatment is to normalize GH levels and alleviate symptoms. Regular monitoring of GH levels, insulin-like growth factor-1 (IGF-1) levels, and clinical response is essential to adjust treatment regimens.
**Correct Answer:** A.